Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportGU

Diagnostic accuracy of 99mTc-Sestamibi SPECT/CT with visual and quantitative interpretation for the characterization of solid renal lesions

Ashwin Singh Parihar, Joyce Mhlanga, Carrie Ronstrom, Lisa Schmidt, Robert Figenshau, Farrokh Dehdashti and Richard Wahl
Journal of Nuclear Medicine August 2022, 63 (supplement 2) 2617;
Ashwin Singh Parihar
1Mallinckrodt Institute of Radiology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joyce Mhlanga
1Mallinckrodt Institute of Radiology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carrie Ronstrom
2Washington University in St. Louis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisa Schmidt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Figenshau
2Washington University in St. Louis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Farrokh Dehdashti
3Mallinckrodt Inst.Of Rad, Nuclear Medicine Dept
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard Wahl
1Mallinckrodt Institute of Radiology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Article Information

vol. 63 no. supplement 2 2617

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online August 8, 2022.

Copyright & Usage 
© 2022

Author Information

  1. Ashwin Singh Parihar1,
  2. Joyce Mhlanga1,
  3. Carrie Ronstrom2,
  4. Lisa Schmidt,
  5. Robert Figenshau2,
  6. Farrokh Dehdashti3 and
  7. Richard Wahl1
  1. 1Mallinckrodt Institute of Radiology
  2. 2Washington University in St. Louis
  3. 3Mallinckrodt Inst.Of Rad, Nuclear Medicine Dept

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: August 2022 to April 2025

AbstractFullPdf
Aug 20221700
Sep 20222500
Oct 20221700
Nov 20222300
Dec 2022800
Jan 20231300
Feb 2023600
Mar 20231400
Apr 2023600
May 20236800
Jun 2023800
Jul 2023700
Aug 20231000
Sep 2023300
Oct 2023600
Nov 2023600
Dec 20231000
Jan 2024500
Mar 2024800
Apr 20244300
May 2024900
Jun 20243900
Jul 202411000
Aug 20249200
Sep 20242100
Oct 2024300
Nov 2024600
Dec 2024200
Jan 2025400
Feb 2025800
Mar 2025900
Apr 2025900
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 63, Issue supplement 2
August 1, 2022
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Diagnostic accuracy of 99mTc-Sestamibi SPECT/CT with visual and quantitative interpretation for the characterization of solid renal lesions
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Diagnostic accuracy of 99mTc-Sestamibi SPECT/CT with visual and quantitative interpretation for the characterization of solid renal lesions
Ashwin Singh Parihar, Joyce Mhlanga, Carrie Ronstrom, Lisa Schmidt, Robert Figenshau, Farrokh Dehdashti, Richard Wahl
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 2617;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Diagnostic accuracy of 99mTc-Sestamibi SPECT/CT with visual and quantitative interpretation for the characterization of solid renal lesions
Ashwin Singh Parihar, Joyce Mhlanga, Carrie Ronstrom, Lisa Schmidt, Robert Figenshau, Farrokh Dehdashti, Richard Wahl
Journal of Nuclear Medicine Aug 2022, 63 (supplement 2) 2617;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Changes in Quantitative PSMA PET Metrics and PSA Progression-Free Survival following Initiation of Androgen Deprivation Therapy in Prostate Cancer Patients: a retrospective single-center study
  • Radiomics features of PSMA-based 18F-DCFPyL PET/MRI for prediction of progression in men with high-risk primary prostate cancer undergoing neoadjuvant chemohormonal therapy
  • A Pilot Study of 68Ga-PSMA11 and 68Ga-RM2 PET/MRI for Biopsy Guidance in Patients with Suspected Prostate Cancer
Show more GU

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire